{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:44:54Z","timestamp":1788871494032,"version":"build-2803163510"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100020968","name":"Boehringer Ingelheim Animal Health GmbH","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020968","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pimobendan and benazepril are frequently used with diuretics to treat dogs in congestive heart failure (CHF) caused by myxomatous mitral valve disease (MMVD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To compare the short-term effects of pimobendan versus benazepril on pump function, heart size, and neuroendocrine profile in dogs with CHF caused by MMVD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Sixteen client-owned dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>Seven-day prospective single-blinded study of dogs stabilized on furosemide monotherapy, randomized to pimobendan (0.4\u20130.6 mg\/kg\/day) or benazepril (0.25\u20131.0 mg\/kg\/day). Dogs had first-pass radionuclide angiocardiography, and heart size was measured by radiography and echocardiography. Circulating neuroendocrine hormones were measured.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline variables did not differ between treatment groups. Greater decreases in the pimobendan than in the benazepril group were found for heart rate (P = .001), heart rate-normalized pulmonary transit time (P = .02), left atrial size (P = .03), and systolic and diastolic left ventricular diameters (P &amp;lt; .001 and P = .03, respectively) and volumes (P &amp;lt; .001 and P = .02, respectively), whereas ejection fraction increased more (P = .02) in the pimobendan group. Of the neuroendocrine hormones, only N-terminal proatrial natriuretic peptide (NT-ProANP) differed (P = .04) between groups. Within groups, plasma aldosterone increased (P = .01), and NT-proANP (P = .01) and NT-proB-type (P = .02) natriuretic peptide decreased in the pimobendan group, and NT-proANP (P = .02) and plasma vasopressin (P = .01) decreased in the benazepril group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Pimobendan improves short-term cardiac function more than benazepril in dogs with CHF caused by MMVD. Pimobendan treatment enables the heart to work at smaller end-systolic and diastolic dimensions while maintaining adequate forward stroke volume. Some of the treatment responses found in neuroendocrine profile might have therapeutic relevance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.12217","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T12:09:39Z","timestamp":1381838979000},"page":"1452-1462","source":"Crossref","is-referenced-by-count":22,"title":["Short-Term Hemodynamic and Neuroendocrine Effects of Pimobendan and Benazapril in Dogs with Myxomatous Mitral Valve Disease and Congestive Heart Failure"],"prefix":"10.1093","volume":"27","author":[{"given":"J.","family":"H\u00e4ggstr\u00f6m","sequence":"first","affiliation":[{"name":"Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Clinical Sciences, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Lord","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Clinical Sciences, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"H\u00f6glund","sequence":"additional","affiliation":[{"name":"Physiology and Biochemistry, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Anatomy, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ljungvall","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Clinical Sciences, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"J\u00f6ns","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Animal Health GmbH , Ingelheim,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kvart","sequence":"additional","affiliation":[{"name":"Physiology and Biochemistry, Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Anatomy, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hansson","sequence":"additional","affiliation":[{"name":"Faculty of Veterinary Medicine and Animal Science, Swedish University of Agricultural Sciences Department of Clinical Sciences, , Uppsala,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2026020304312202500_jvim12217-bib-0001","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure","volume":"213","author":"Ettinger","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304312202500_jvim12217-bib-0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","article-title":"The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial","volume":"1","author":"The BENCH Study Group","year":"1999","journal-title":"J Vet Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0004","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST Study","volume":"22","author":"H\u00e4ggstr\u00f6m","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/0420249","article-title":"Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs","volume":"42","author":"Lombard","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020304312202500_jvim12217-bib-0006","first-page":"43","article-title":"Effect of treatment type on vertebral heart size in dogs with myxomatous mitral valve disease","volume":"5","author":"Wolley","year":"2007","journal-title":"Int J Appl Res Vet Med"},{"key":"2026020304312202500_jvim12217-bib-0007","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1939-1676.2003.tb02521.x","article-title":"Increased pulmonary transit times in asymptomatic dogs with mitral regurgitation","volume":"17","author":"Lord","year":"2003","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0008","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/00365517909106127","article-title":"Quantitative radiocardiographic evaluation of cardiac dynamics in man at rest and during exercise","volume":"39","author":"Kuikka","year":"1979","journal-title":"Scan J Clin Lab Invest"},{"key":"2026020304312202500_jvim12217-bib-0009","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1939-1676.2010.0619.x","article-title":"Pulmonary blood volume in mitral regurgitation in Cavalier King Charles Spaniels","volume":"24","author":"Eriksson","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0010","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"H\u00e4ggstr\u00f6m","year":"1996","journal-title":"Am J Vet Res"},{"key":"2026020304312202500_jvim12217-bib-0011","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root root indices using two-dimensional and M-mode echocardiography in dogs with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020304312202500_jvim12217-bib-0012","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","article-title":"Allometric scaling of M-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0013","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2460\/javma.1995.206.02.194","article-title":"Vertebral scale system to measure canine heart size in radiographs","volume":"206","author":"Buchanan","year":"1995","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304312202500_jvim12217-bib-0014","first-page":"134","volume-title":"Essentials of Canine and Feline Electrocardiography","author":"Tilley","year":"1985","edition":"2nd ed"},{"key":"2026020304312202500_jvim12217-bib-0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"Am J Vet Res"},{"key":"2026020304312202500_jvim12217-bib-0016","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2460\/ajvr.2005.66.1709","article-title":"Vasopressin, cortisol, and catecholamine concentrations in dogs with dilated cardiomyopathy","volume":"66","author":"Tidholm","year":"2005","journal-title":"Am J Vet Res"},{"key":"2026020304312202500_jvim12217-bib-0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tvjl.2007.12.026","article-title":"Predictive value of natriuretic peptides in dogs with mitral valve disease","volume":"180","author":"Tarnow","year":"2009","journal-title":"Vet J"},{"key":"2026020304312202500_jvim12217-bib-0018","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-3565(24)36774-6","article-title":"The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure","volume":"282","author":"Ohte","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"2026020304312202500_jvim12217-bib-0019","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1476-5381.1996.tb15716.x","article-title":"Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs","volume":"119","author":"Pagel","year":"1996","journal-title":"Br J Pharmacol"},{"key":"2026020304312202500_jvim12217-bib-0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","article-title":"Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: Results of the Invasive Multicenter PROspective Veterinary Evaluation of enalapril study","volume":"9","author":"The IMPROVE Study Group","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0021","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1939-1676.2010.0672.x","article-title":"The effect of furosemide on left atrial pressure in dogs with mitral valve regurgitation","volume":"25","author":"Suzuki","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0022","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tvjl.2009.06.008","article-title":"Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs","volume":"185","author":"Hori","year":"2010","journal-title":"Vet J"},{"key":"2026020304312202500_jvim12217-bib-0023","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jacc.2009.11.103","article-title":"Looking into the left atrial crystal ball: A ray of hope for patients with organic mitral regurgitation","volume":"56","author":"Levine","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0024","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1292\/jvms.69.373","article-title":"Effects of pimobendan for mitral valve regurgitation in dogs","volume":"69","author":"Kanno","year":"2007","journal-title":"J Vet Med Sci"},{"key":"2026020304312202500_jvim12217-bib-0025","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1939-1676.2011.00800.x","article-title":"The effect of pimobendan on left atrial pressure in dogs with mitral valve regurgitation","volume":"25","author":"Suzuki","year":"2011","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0026","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvc.2012.02.001","article-title":"Pathology of myxomatous mitral valve disease in the dog","volume":"14","author":"Fox","year":"2012","journal-title":"J Vet Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2460\/javma.1984.184.04.455","article-title":"Myocardial function in small dogs with chronic mitral regurgitation and severe congestive heart failure","volume":"184","author":"Kittleson","year":"1984","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304312202500_jvim12217-bib-0028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1939-1676.2007.tb02929.x","article-title":"Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency","volume":"21","author":"Borgarelli","year":"2007","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0029","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00005344-198406060-00012","article-title":"Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure","volume":"6","author":"Sweet","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"2026020304312202500_jvim12217-bib-0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jvc.2012.01.012","article-title":"Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs","volume":"14","author":"Dillon","year":"2012","journal-title":"J Vet Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0031","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1440-1681.2003.03879.x","article-title":"Cardiac energetics: From E(max) to pressure-volume area","volume":"30","author":"Suga","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2026020304312202500_jvim12217-bib-0032","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.107.755942","article-title":"Left ventricular response to mitral regurgitation: Implications for management","volume":"118","author":"Gaasch","year":"2008","journal-title":"Circulation"},{"key":"2026020304312202500_jvim12217-bib-0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvc.2006.11.001","article-title":"Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio","volume":"9","author":"Gardner","year":"2007","journal-title":"J Vet Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0034","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2460\/ajvr.1997.58.01.77","article-title":"Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs","volume":"58","author":"H\u00e4ggstr\u00f6m","year":"1997","journal-title":"Am J Vet Res"},{"key":"2026020304312202500_jvim12217-bib-0035","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.2460\/ajvr.72.12.1646","article-title":"Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs","volume":"72","author":"Lantis","year":"2011","journal-title":"Am J Vet Res"},{"key":"2026020304312202500_jvim12217-bib-0036","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1939-1676.2009.0367.x","article-title":"Acute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs","volume":"23","author":"Sayer","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0037","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2885.2012.01406.x","article-title":"Capturing the dynamics of systemic renin-angiotensin-aldosterone system (RAAS) peptides heightens the understanding of the effect of benazepril in dogs","volume":"36","author":"Mochel","year":"2013","journal-title":"J Vet Pharmacol Therap"},{"key":"2026020304312202500_jvim12217-bib-0038","first-page":"150","article-title":"Vasopressin and blood pressure regulation","volume":"6","author":"Cowley","year":"1988","journal-title":"Clin Physiol Biochem"},{"key":"2026020304312202500_jvim12217-bib-0039","doi-asserted-by":"crossref","first-page":"9J","DOI":"10.1016\/S0002-9149(97)00832-1","article-title":"The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease","volume":"80","author":"Cody","year":"1997","journal-title":"Am J Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1388-9842(00)00104-5","article-title":"Relationship between left ventricular wall stress and ANP gene expression during the evolution of rapid ventricular pacing-induced heart failure in the dog","volume":"2","author":"Luchner","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"2026020304312202500_jvim12217-bib-0041","first-page":"H1684","article-title":"Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure","volume":"274","author":"Luchner","year":"1998","journal-title":"Am J Physiol"},{"key":"2026020304312202500_jvim12217-bib-0042","doi-asserted-by":"crossref","first-page":"9483","DOI":"10.1073\/pnas.93.18.9483","article-title":"Secretory granule targeting of atrial natriuretic peptide correlates with its calcium-mediated aggregation","volume":"93","author":"Canaff","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026020304312202500_jvim12217-bib-0043","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","article-title":"Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure","volume":"90","author":"Yasue","year":"1994","journal-title":"Circulation"},{"key":"2026020304312202500_jvim12217-bib-0044","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1939-1676.2012.00894.x","article-title":"The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease","volume":"26","author":"Hezzell","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020304312202500_jvim12217-bib-0045","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jvc.2012.05.005","article-title":"Lowered N-terminal pro-B-type natriuretic peptide levels in response to treatment predict survival in dogs with symptomatic mitral valve disease","volume":"14","author":"Wolf","year":"2012","journal-title":"J Vet Cardiol"},{"key":"2026020304312202500_jvim12217-bib-0046","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.RES.64.4.799","article-title":"Chronotropic stimulation: A primary effector for release of atrial natriuretic factor","volume":"64","author":"Bilder","year":"1989","journal-title":"Cirk Res"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.12217","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.12217","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.12217","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/6\/1452\/66684651\/jvim12217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/27\/6\/1452\/66684651\/jvim12217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:31:46Z","timestamp":1770111106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/27\/6\/1452\/8451893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.12217","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,11,1]]}}}